Neoplasms Clinical Trials in Los Angeles, California

6 studies are recruiting for neoplasms in Los Angeles, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

   This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o…

   Stage

   Phase 2

   Ages

   Any age

   Site

   Local Institution - 01206, Los Angeles, California

   Locations

   222 in total

   Run by

   Celgene

   See if you can join NCT03435796 on ClinicalTrials.gov

2. Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer

   This is a multi-site, global, open-label study that includes a phase 1b evaluation of elacestrant in combination with abemaciclib in women and men with brain metastases from estrogen receptor (ER)-positive, human epidermal growth factor receptor-2 (HER-2) negative breast cancer. Phase 1b was design…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   California Research Institute, Los Angeles, California

   Locations

   86 in total

   Run by

   Stemline Therapeutics, Inc.

   See if you can join NCT05386108 on ClinicalTrials.gov

3. Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

   This open-label, dose-finding, and proof of concept study will evaluate the safety, tolerability, maximum-tolerated dose (MTD) and/or optimal dose of nenocorilant when administered in combination with nivolumab in patients with advanced solid malignancies.

   Stage

   Phase 1

   Ages

   18 and older

   Site

   Site 03, Los Angeles, California

   Locations

   5 in total

   Run by

   Corcept Therapeutics

   See if you can join NCT07276373 on ClinicalTrials.gov

4. A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

   The main purpose of the master is to help the research sites and sponsor carry out several clinical trials more efficiently by providing a common research protocol. Individual clinical trials under this master protocol define drug/disease-specific research goals and activities to test them. New stu…

   Stage

   Phase 2

   Ages

   1 to 39

   Site

   Childrens Hospital of Los Angeles, Los Angeles, California

   Locations

   72 in total

   Run by

   Eli Lilly and Company

   See if you can join NCT05999994 on ClinicalTrials.gov

5. Bladder Fiducial Markers and Multiparametric-MRI (Mp-MRI) to Optimize Bladder Chemo-radiotherapy

   The purpose of this study is to examine the usefulness of implanting small 24-K gold fiducial markers around a bladder tumor site, so that a Radiation Oncologist can identify the original tumor location at the time of radiation treatment. Other goals of the study include assessing whether a new MRI…

   Stage

   Not phased

   Ages

   18 and older

   Site

   Cedars-Sinai Medical Center (CSMC), Los Angeles, California

   Locations

   3 in total

   Run by

   Cedars-Sinai Medical Center

   See if you can join NCT04442724 on ClinicalTrials.gov

6. 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer

   This a single-center, prospective, exploratory study. Patients with metastatic castration-resistant prostate cancer (mCRPC) scheduled to undergo Lutetium labelled prostate-specific membrane antigen radioligand therapy (LuPSMA RLT) at the West Los Angeles VA (WLA-VA) will be imaged with a baseline F…

   Stage

   Phase 4

   Ages

   18 and older

   Site

   VA Greater Los Angeles Healthcare System, Los Angeles, California

   Run by

   VA Greater Los Angeles Healthcare System

   See if you can join NCT06706921 on ClinicalTrials.gov